In fact, in patients with acute myeloid leukaemia (AML), the suboptimal expression of NKG2D ligands has been described as an escape mechanism of tumour cells from NK cell recognition [61], confirming that these molecules can affect the susceptibility of cancer cells to innate responses. Here, KLRK1 is linked to cancer.